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Given the increasing demand for practical and low-cost analytical techniques, biosensors have attracted 
attention for use in the quality analysis of drugs, medicines, and other analytes of interest in the 
pharmaceutical area. Biosensors allow quantification not only of the active component in pharmaceutical 
formulations, but also the analysis of degradation products and metabolites in biological fluids. Thus, 
this article presents a brief review of biosensor use in pharmaceutical analysis, focusing on enzymatic 
electrochemical sensors.
Uniterms: Biosensors. Pharmaceutical analysis. Electrochemical sensors. Enzymes.
Em virtude do aumento da demanda por técnicas analíticas simples e de baixo custo, os biossensores têm 
atraído a atenção para a análise de fármacos, medicamentos e outros analitos de interesse em controle 
de qualidade de medicamentos. Os biossensores permitem a quantificação não somente de princípio 
ativo em formulações farmacêuticas, mas também de produtos de degradação e metabólitos em fluídos 
biológicos, bem como análise de amostras de interesse clínico e industrial, além de possibilitar a 
determinação de enantiômeros. Desta forma, este artigo objetiva fazer uma breve revisão a respeito do 
emprego de biossensores em análise farmacêutica, com ênfase em sensores eletroquímicos enzimáticos.
Unitermos: Biossensores. Análise farmacêutica. Sensores eletroquímicos. Enzimas.
INTRODUCTION
Both research and development of pharmaceuti-
cal analysis embraces innovative procedures in a bid to 
combine accuracy, precision, selectivity, and sensitivity 
with simplicity, rapidity and low cost. Hence, the interest 
in biosensors has increased over recent years, since such 
devices consolidate many of these qualities, including sim-
plicity and rapidity. Indeed, due to these characteristics, 
biosensors have been applied to many fields of chemical 
analysis including biomedical, pharmaceutical, food and 
environmental.
Biosensors are composed of two main parts: a bio-
logical recognizing component (enzyme, antibody, cell, 
tissue, etc.) directly connected to a physical transducer 
(voltammetric, amperometric, conductometric, spectro-
photometric, etc) (Kauffman, 2002). The broad variety 
of biological systems that can be used as recognizing 
agents allows specific biosensors for a very large pool of 
analytes. Furthermore, electrochemical transducers confer 
high sensitivity for these devices (Lojou, Bianco, 2006). 
In spite of some significant disadvantages including 
low stability and poor reproducibility, which have been 
an obstacle to biosensor applications in quality control of 
medicines, the advantages outlined have kept biosensors 
a scientific focus (Kaufman, 2002).
The physicochemical interaction between analyte 
and the bio-recognizing agent is monitored by a transdu-
cer. In the case of electrochemical biosensors, the signal 
detection occurs at the electrode/solution interface, which 
can be dynamic or static. In dynamic methods, i.e. vol-
tammetry (amperometric biosensor), the interaction must 
involve a redox process followed by electron transfer. In 
static methods (potentiometry) however, the concentration 
of charged species, as a function of the electrochemical 
potential, is monitored by a potentiometric biosensor 
(Ravishankara, Pillai, Handral, 2001). The use of either 
biosensor depends on the characteristics of the analyte. 
Thus, for amperometric biosensors, inorganic or organic 
species must undergo a redox process at working poten-
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tials, i.e. electroactive species, while static methods are 
applicable to charged species (Stradiotto et al., 2003). The 
correct choice of the recognizing agent and transducer, 
both suited to the target molecule, is the key to achieving 
an optimum biosensor.
Since the first description of biosensors based on 
glucose-oxidase, many configurations have been propo-
sed for these devices in an effort to improve transduction 
mechanisms, molecular recognizing systems and immobi-
lization of biological components (Yu et al., 2005). Among 
the most widely used recognizing agents are enzymes (e.g. 
peroxidases, phenoloxidases and sterases), antibodies, 
drug receptors, and DNA. The use of entire cells or tissues, 
as well as other components, is less common in biosensors 
applied to pharmaceutical analysis (Yu et al., 2005).
The level of specificity of the recognizing agent is 
based not only on the intrinsic structural properties of the 
biological component, but also on the way that compo-
nent is immobilized on the transducer, enabling systems 
capable of discriminating two enantiomers or only one 
chemical class (Stefan et al., 1999). The transducer sys-
tem converts a chemical signal into a measurable signal. 
The transducers can be classified into: potentiometric, 
amperometric, conductometric, optical, entalpimetric, or 
piezoelectrical (Pereira et al., 2002). In electrochemical 
biosensors, the main transducing elements include support 
electrodes of noble metals (e.g. Pt and Au) and carbon deri-
vatives (e.g. glassy carbon, carbon paste). These electrodes 
can be modified in order to improve the connection with 
the recognizing agent, being applicable for pharmaceuti-
cal and biomedical analysis of a large variety of samples 
(Nakamura, Karube, 2003; Uslu, Bengi, Sibel, 2007; Oe-
zkan, Uslu, Aboul-Enein, 2003, Uslu et al., 2007).
The substantial advances in materials science and 
nanotechnology has led to significant development of 
many electrochemical transducers, such as:
a)  Development of conductive polymers with suitable 
characteristics for electrochemical sensors, for 
example: ultrathin films, low electrical resistivity 
and suitable functional groups for immobilization 
of recognizing agent (Malhotra et al., 2006);
b)  Development of carbon nanotubes, which often offer 
a larger superficial area for signal transduction, as 
well as for immobilization of enzymes, DNA or even 
for pre-concentration of electroactive molecules 
(He, Xu, Fang, 2006).
c)  Development of nanomaterial with molecular di-
mensions, i.e. porous and monodispersive particles 
of clays with high superficial area, resulting in high 
sensitivity (10 picomolar) (Mousty, 2004);
d)  Development of biomimetic ionophore channels that 
respond selectively to specific drugs (Kohli, Wirtz, 
Martin, 2004; Keusgen, 2002).
However, the efficient immobilization of recogni-
zing agents for transducers remains a major challenge 
in biosensor technology. The optimization of analytical 
signal involves the suitable immobilization of biological 
component to the physical component. Many techniques 
of immobilization have been proposed. Crosslinking be-
tween functional polymer groups and bio-components in 
polymeric matrices, self-assembled monolayer techniques 
(SAMS), thin co-electropolymerization with electron me-
diators and conductive systems number some examples of 
these techniques (Nakamura, Karube, 2003).
The main parameters of immobilization efficiency 
are the guarantee of selectivity, sensitivity and stability. 
Biosensor stability is associated with the reproducibility of 
the response and depends mainly on the binding force be-
tween the biological element and the transducer (Nakamu-
ra, Karube, 2003). It is worth noting that immobilization 
allows a favorable environment for the maximum activity 
of the biological system. The association between enzy-
mes and DNA or other natural polymers has been widely 
explored. Enzymes and DNA co-immobilization in ultra-
thin polymeric monolayer has resulted in high sensitivity 
and selective systems for analytical and pharmacological 
purposes (Dantoni et al., 1998; Rusling et al., 2008).
The technology of screen-printed electrodes in 
biosensor development has also received much attention 
(Nascimento, Angnes, 1998; Freire et al, 2002; Hart, 2004; 
Soares et al., 2007). Suprun et al (2005), optimized acetyl-
cholinesterase biosensors for detection of carbamates and 
organophosphorus pesticides by using the screen-printed te-
chnique and electron mediators to modify carbon electrodes.
This article presents a brief review of the applica-
tions of electrochemical biosensors in pharmaceutical 
analysis.
BIOSENSORS IN PHARMACEUTICAL 
ANALYSIS
Given that the pharmacopeia methods are often time-
consuming and expensive, biosensors have become an 
interesting alternative. Much research has been carried out 
towards the optimization of immobilization techniques, and 
in the obtention of the analytical signal. Novel biological 
and biomimetic recognizing systems have been explored 
(Fatibello-Filho, 2007; Lowe, 1999). A few examples of 
biological recognizing agents coupled with electrochemical 
transducers include the use of enzyme aryl-acyl-amidase 
to detect aminophenol delivered from acetaminophen for 
the indirect analysis of paracetamol samples; the use of 
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teophilin oxidase coupled with the electron mediator (fer-
rocyanate) for theophylline analysis; salicylate hydroxylase 
for the detection of salicylate in the presence of NADH and 
oxygen; tyrosinase for analysis of phenolic compound, 
catecholamines and peroxides (Wang, 1999).
The analytical strategies employed in the develo-
pment of biosensors range from the detection of a signal 
generated by the direct interaction between the analyte and 
the recognizing agent, or indirectly, involving mediators 
and coupling reactions. 
The majority of biosensors are based on enzymatic 
reactions, whereby the nature of the products in the bio-
chemical reaction, as well as the molecular characteristics 
of the analyte, determine the best kind of transducer to be 
utilized (Pereira, Santos, Kubota, 2002).
Concerning oxidizible drugs, the best choice would 
be amperometric transducers and the enzymes: peroxida-
ses, laccases, tyrosinase, superoxide dismutase, among 
other oxidases which could be used as the biological 
component in molecular recognizing (Erdem, 2000; Fe-
rapontova, 2007; Gil, 2009).
Electron transfers from enzymatic reactions to the 
electrode surface can occur by three mechanisms, defining 
the type of amperometric biosensor used, which can be 
classified into three generations:
1)  The first generation electrodes are based on the redox 
behavior of cofactors, (ß-NAD(P)+.). 
2)  The second generation has incorporated the use of 
electron mediators in order to reduce potential and 
improve electron transfer and sensitivity.
3)  In the third generation electrodes, the electron 
transfer occurs directly between the active center 
of enzyme and electrodic material (Oliveira-Neto 
et al., 1999).
Regarding drugs containing hydrolysable and labile 
groups and/or when there is proton H+ liberation, the use 
of ion-selective electrodes or potentiometric biosensors 
is the most frequently used alternative (Liu et al., 1998; 
Couto, Montenegro, 2000; Shvedene, Borovskaya, 2003; 
Ozoemena et al., 2005).
Among the promising perspectives concerning the 
future of biosensors is the use of biomimetic models, 
which combine improved chemical stability with similar 
activity of the respective enzyme (Tan et al., 2001; Kin-
dschy, Alocilja, Evangelyn, 2007).
ANTI-INFLAMMATORY AND ANALGESIC 
DRUGS
The drugs belonging to the NSAID (Non Steroidal, 
Anti-inflammatory Drug) therapeutical class are the most-
consumed in the world. They are subdivided into three or 
more classes, according to selectivity for cyclooxogenase 
I and II (Goodman, Gilman, 1996). In view of the number 
of analyses carried out every day, research furthering the 
development of alternative methods that combine high-
speed and simplicity with low cost is justified.
Salicylates
Due to its simplicity and rapidity, Trinder´s method 
is the most widespread methodology for salicylate analy-
sis. However, this method is subject to interference from 
enolic and phenolic groups (Gil, 2007; Oliveira-Neto et 
al., 1999). Moreover, instrumental methods, e.g. High 
Performance Chromatography (Friederkees, Grobecker, 
1996) and UV-spectrophotometry (Kokot, Burda, 1998) 
are time consuming and require one or more sample pre-
paration steps (Júnior et al., 2000). In this context, electro-
analysis and the use of biosensors can be very promising. 
Given the possibilities of obtaining measurements at low 
potentials, the use of electron mediators is an interesting 
option. In addition, the second generation amperometric 
biosensors are cheaper than other technologies (Moore et 
al., 1995). 
A number of biosensors based on Salicylate Hydro-
xylase (SH) (EC 1.14.13.1), alone or coupled to other 
enzymes, i.e., glucose oxidase (EC 1.1.3.4) or tyrosinase 
(EC 1.14.18.1) have been proposed (Frew et al., 1989; 
Oliveira-Neto et al., 1999; Campanella et al., 2006; Cui 
et al., 2008). In these systems, the analytical signal is 
obtained by electron transfer during the oxireduction of 
cathecolic product, which results from the hydroxylation 
and descarboxylation of salicylate (Oliveira-Neto et al., 
1999).
Quantification of salicylate in the range of 7.25 10-6 
mol L-1 to 4.35 x 10-3 molL-1 was possible with the use of 
Salicylate hydroxylase (SH) biosensor. The biosensor was 
constructed by the direct immobilization of SH enzyme on 
platinum electrodes with the use of glutaraldehyde cross 
linker and polypyrrole conductive films containing he-
xacyanoferrate electron mediator. Flow injection analysis 
systems were employed in this work in order to improve 
the quality and number of measurements (Milagres, 1997; 
Neumayr el al, 1995. Carbon paste bi-enzymatic biosen-
sors based on the immobilization of SH and tyrosinase is 
also widespread. A detection limit of 3.5 x 10-6 mol.L-1 was 
obtained for salicylate by using this simple system (Mar-
tin, 1999). Indeed, the use of bi or tri enzymatic systems 
improves sensitivity at lower working potentials (Moore 
et al., 1995; Scheller, Scheller, 1996; Cosnier et al., 2001; 
Cui et al., 2008). The type of transducing element, tech-
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nique of immobilization of the recognizing agent, and 
use of electron mediators can also define the sensitivity, 
stability and applicability of biosensors (Kubota et al., 
1997; Oliveira-Neto, 1999). The use of carbon fibers for 
SH immobilization was applied in the development of bio-
sensors for in situ analysis. Furthermore, the architecture 
of this microelectrode defined the level of sensitivity and 
stability (Carvalho et al., 2000 and 2001).
Moreover, the SH enzyme occlusion in conductive 
polymeric films (e.g. polypyrrole) is another widespread 
immobilization technique (Oubina et al., 1997; Rover-
Junior et al., 2000). 
The immobilization of SH by covalent bond with 
p-tetrachloroquinone, resulted in stable linking allowing 
the reuse of the enzymatic system for more than one year 
(Neumayr et al; 1995; Oliveira-Neto et al., 1999). 
Recently, a biosensor based on superoxide dismu-
tase enzyme was developed to evaluate the antioxidant 
and radical scavenger activity of phenolic compounds 
in aerated medium. This study included the salicylate 
derivatives, and the principle of detection was based on 
the dismutation of superoxide into oxygen and hydrogen 
peroxide (Emregul 2005).
Acetaminophen
In the presence of hydrogen peroxide, the Horsera-
dish peroxidase (HRP) [EC 1.11.1.7] catalyzes the oxi-
dation of paracetamol (acetaminophen) into N-acetyl-p-
benzoquinoneimine. Hence, the amperometric biosensors 
based on direct enzyme immobilization on the transducer 
surface are the main analytical strategies used for parace-
tamol analysis (Messina, De-Vito, Raba, 2006).
Among the innumerous procedures carried out toward 
performance optimization of such devices is that based on 
nanotechnology. Enzyme immobilization in carbon na-
notubes, nanoporous enriched particles, always results in 
improvement of the transducer surface area and consequent 
gain in sensitivity (Zhai et al., 2006; Sima et al.,2008).
In this context, the HRP was immobilized in na-
noporous magnetized microparticles of silica for the 
construction of carbon paste biosensors with enhanced 
performance. The use of such magnetized microparticles 
allows better fixing of the enzyme to the carbon paste 
electrode, resulting in improved stability. Furthermore, the 
increased surface area allowed the quantification of para-
cetamol at micromolar levels, while the enzyme occlusion 
in the nanoporous particles reduced its susceptibility to 
interference from tiols (Yu et al., 2006).
The development of HRP biosensors for paraceta-
mol detection in miniaturized systems for online monito-
ring has also been proposed. Such devices make possible 
paracetamol assays in pharmaceutical formulations in a 
linear range from 0.35 to 100 x 10-6 mol.L-1. This system 
presented a high level of precision and accuracy and a 
detection limit of 3 x 10-7 molL-1 (Messina, De-Vito, Raba, 
2006).
Conductive materials often contributes to the 
analytical signal and warrant recognition in the deve-
lopment of biosensors (Hoshi et al., 2000). Boopathi et 
al (2004) developed a paracetamol biosensor which had 
its glassy carbon transducer modified with conductive 
polymer and cooper (II) complex. The use of this polymer 
prevents the surface block caused by samples and increa-
sed the sensitivity of the sensor. Furthermore, additional 
pre-treatment steps were avoided.
The modification of transducers with natural enzy-
mes obtained from vegetals is a practical, very interesting 
option, especially in Brazil. The peroxidases can be found 
in natural sources, including zucchini and avocado, pre-
senting the great advantage of low cost. Moreover, the 
use of vegetal tissues provides higher enzymatic stability, 
since the enzymes are found in the natural environment 
(Fatibello-Filho et al., 2001; Vieira et al., 2003).
Another interesting model constitutes the use of 
tyrosinase as a recognizing agent (Wang, Naser, Wollen-
berger, 1993). The use of this enzyme in the presence of 
3-methyl-2-benzothiazolone hydrazone, a powerful nucle-
ophilic agent, enables quantitative analysis of paracetamol 
in a wide range of concentrations (Valero et al., 2003).
Among the strategies of immobilization most em-
ployed in tyrosinase, is occlusion in conductive polymeric 
membranes (Kim, Lee, 2003). Other strategies suggest 
the use of screen printed electrodes (Wang et al., 2007).
Laccase is another phenoloxidase used as a re-
cognizing agent in the development of paracetamol 
biosensors. The co-immobilization of this enzyme with 
1-hydroxybenzotriazole, an electron mediator, has resulted 
in a highly sensitive biosensor with detection limits of 
submicromolar levels (Odaci et al., 2006). Besides oxi-
dases, the hydrolase, aril-acilamidase, responsible for the 
conversion of acetaminophen into 4-aminophenol, have 
also been evaluated in paracetamol analysis. The resulting 
biochemical product of the reaction was detected at +250 
mV by amperometric biosensor, and the concentration of 
paracetamol was indirectly quantified (Vaughan, 1991).
NEUROTRANSMITTERS DRUGS
The electrochemical methods are especially use-
ful in the study of neurotransmitters (NT) and neuronal 
drugs, not only from a quality control point of view, but 
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also for physiological purposes. Voltammetry coupled to 
microelectrodes modified with drug or NT receptors are a 
useful tool for evaluating the physiopathological process, 
elucidating their pharmacological mechanism of action, as 
well as for the development of new drugs (Crespi, 1995; 
Urban, 2001; Crespi, 2002).
Catecholamine
Catecholamines exert many functions at both the 
central and autonomous nervous systems (Silva, Menezes, 
Kempinas, 2007). These molecules have an oxidized ca-
thecolic group which can be catalyzed by many oxidases.
The use of vegetal tissues as a source of oxidases for 
biosensor purposes represents a very promising alternative 
for the quantification of this class of molecules (Gil et al., 
2008; Fatibelo-Filho et al., 2001; Vieira et al., 2003).
The enzyme polyphenoloxidase, present in coconut 
fiber tissues (Lima et al., 1997), apple (Cummings et al., 
1998), avocado (Fatibello-Filho et al.,2001), zucchini 
(Lupetti et al., 2005), potato (Vieira, Fatibello-Filho et al., 
2000), and many kinds of palms (Gil et al., 2008; Felix 
et al., 2006) have been used as source of enzymes for 
biosensor development focusing on the analysis of mole-
cules containing cathecolic and phenolic groupings. The 
polyphenoloxidases catalyze the hydroxylation of phenols 
to cathecoles, acting as a cathecolase, and in the oxidation 
of the resulting cathecoles to the respective quinones, 
exerting their oxidase activity. Due their high selectivity 
and activity, as well the capacity to act as a direct electron 
receptor, these enzymes have great analytical potential 
(Toralles et al., 2004; Fatibello-Filho, Vieira, 2002). 
Biosensors containing palm fruit (Livistona chi-
nensis) have been used for the analysis of epinephrine in 
pharmaceutical formulations at the concentration range 
of 0.05 to 0.35mM. In comparison to official methods 
(USP XXX), the results presented great accuracy (3.1%) 
and repeatability (Felix, Yamashita, Angnes, 2006). Other 
palm tissue-based biosensors for catecholamine analysis 
include the coconut (cocconuts) biosensor (Lima et al., 
1997) and the guariroba (Syagrus oleracea) biosensor 
(Gil et al., 2008).
A biosensor comprising 25% (p/p) polyphenoloxi-
dase obtained from banana tissues (Annona muricata L.), 
30% (p/p) graphite, 30% (p/p) silicone oil, and 15% (p/p) 
of 7,7,8,8 tetracyanoquinodimethane (TCNQ) coupled to 
flow injection systems (FIA) was successfully used for 
the determination of dopamine in pharmaceutical formu-
lations. Amperometric detection was performed at 100 
mV (vs Ag/AgCl), pH 7.8 and a 2.5 mL/min flow rate. 
A linear curve from 0.1 to 20 mmolL-1 was obtained for 
both experimental (RSD = 1.5%) and real (RSD = 3.4%) 
samples (Bezerra et al., 2003).
Another economical source of enzymes includes the 
use of microbial cultures, e.g.: crude extracts of laccase 
from various fungi (Gil et al., 2009; Freire et al., 2001). 
Recovery rates of between 97.3 and 101% for adrenaline, 
and between 95.8 and 102% for dopamine, as well as 
good correlation from 0.05 to 0.5 mmolL-1 was obtained 
for carbon paste biosensors prepared with crude extract 
of laccase (Pleurotus ostreatus). Moreover, a confidence 
level of 95% was obtained for analysis of pharmaceuticals 
produced with this biosensor, comparable to the official 
method (Leite, Fatibello-Filho, Barbosa, 2003). 
Another strategy used in the development of biosen-
sors for dopamine analysis is the employment of biomime-
tic receptors in planar bi-layers of lipidic membranes. The 
interaction of dopamine with the NT-receptor produces a 
transient current signal, which is proportional to the con-
centration of the NT or drug analogues (Nikolelis, 2002).
Methylxanthines
Methylxanthines, caffeine, theobromine and teophilin 
act as stimulants of the central nervous systems and also as 
muscle relaxants, being commonly indicated in the treat-
ment of asthma (Goodman, Gilman, 1996). Moreover, these 
compounds can be found in many popular beverages, e.g. 
coffee and teas. The high consumption of these compounds 
justifies the development of new analytical methods.
The majority of scientific studies involving biosen-
sors for the analysis of methylxanthines are aimed at the 
quantification of teophilin. Studies using DNA biosensors 
and other nucleic acids derivatives have been highlighted 
(Ferapontova, Olsen, Gothelf, 2008; Rankin, 2006; 
Sekella, Rueda, Walter, 2002; Buch, Rechnitz, 1989). 
Aptamers of RNA were co-immobilized with ferrocene 
(electron mediator) on gold electrodes. This RNA-based 
biosensor was evaluated for teophilin analysis, by means 
of cyclic and differential pulse voltammetry, presenting a 
linear response from 0.2 to 1.0 mmol.L-1. The conforma-
tional disturbance provoked in the RNA polymer by the 
bronchodilator results in an increase in mediator-electrode 
electron transfer, and as a consequence, in the sensitivity 
of the biosensor. The RNA-biosensor also presented high 
selectivity, even in the presence of interfering compounds, 
such as caffeine and theobromine. Moreover, the pre-
treatment of serum samples with use of RNAase inhibitors 
enables use of this biosensor for clinical analysis (Fera-
pontova, Olsen, Gothelf, 2008).
A xanthine oxidase-based biosensor was proposed for 
the amperometric analysis of teophilin and other xanthenes 
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in biological samples. The detection limit of 2 x 10-7 molL-
1 was obtained for this device, which was stable for more 
than three months of conditioning. The selectivity of the 
xanthine oxidase biosensor was found to be dependent on 
pH, being optimum for xanthine determination at pH 5.5, 
while for teophilin, the best response was found between 
the pH range of 6.5 and 8.5. Moreover, no interference in 
the analytical signal was observed for samples containing 
caffeine or theobromine (Stredansky et al., 2000). 
Teophilin oxidase, isolated from microorganisms, is 
another enzyme that has been explored in the development 
of sensitive and selective biosensors applied to teophilin 
analysis (McNeil, Cooper, Spoors, 1992; Christenson, 
2004; Ferapontova, Shipovskov, Gorton, 2007). Since this 
enzyme is almost inactive for caffeine and theobromine at 
concentrations levels below 100 mgL-1, and 3-methylxhan-
tine (below 50 mgL-1) the selectivity of this enzyme is 
excellent (McNeil, Cooper, Spoors, 1992).
Considering that xanthines inhibit phosphodiestera-
se, biosensors based on such enzymes were also proposed 
(Pizzariello et al., 1999). A phosphodiesterase-based 
biosensor was developed for caffeine analysis in food and 
biological samples, offering a detection limit of 0.6 mg/L 
and linear response from 0.2 to 4 mg/mL. 
Examples of the use of entire cells for the deve-
lopment of xanthine biosensors can also be found in 
the literature. Pseudomonas alcaligenes (MTCC 5264), 
immobilized on electrochemical transducers, resulted in 
a biosensor for caffeine analysis. The principle of analy-
sis is based on the capacity of such microbial cells to 
consume xanthines. The microbial biosensor presented a 
response time of three minutes at the concentration range 
0.1 to 1 mg/mL. This practical method also showed good 
selectivity for real samples in comparative studies with 
high performance chromatography (HPLC) (Babu, 2007). 
The isolation of specific enzymes from microorganisms 
of this species has been carried out by many researchers 
(Mohapatra et al., 2006).
Benzodiazepines
Benzodiazepines are central inhibitors, commonly 
used for anxiety treatment. Since the therapeutical success 
of this class of drugs hinges on the maintenance of strict 
serum levels, many fatal accidents can occur due to the 
consumption of benzodiazepines. Hence, the development 
of methods for benzodiazepines analysis has great impor-
tance in many fields, e.g. quality control, clinical analysis 
and forensic investigations. 
Studies describing the electrochemical behavior 
of temazepam, oxazepam and diazepam on carbon pas-
te electrodes were investigated by means of cyclic and 
pulse differential voltammetry. The optimum conditions 
of response as well as the influence of interfering agents 
in clinical and pharmaceutical samples were evaluated. 
The optimum pH for temazepam and oxazepam was 
determined in the range 3.0 to 5.0. However, diazepam 
responded better in neutral to alkaline pH (7.0-10.5). The 
use of bentonite, an adsorbing agent (5% of carbon paste 
composition), resulted in the improvement of current le-
vels. This fact can be associated to the pre concentration 
effect. However, these simple systems have not conferred 
suitable selectivity, a characteristic that can be achieved by 
the use of biological recognizing agents (Lozano-Chaves 
et al., 2006).
Neuroleptics and Antidepressants
Neuroleptics or antipsychotics as well as antidepres-
sants are drugs used in the treatment of psychiatric disor-
ders. Among the main chemical class of antipsychotics are 
the heterocyclic compounds, such as thioxanthenes and 
phenothiazines, while the main antidepressants include 
MAO (Monoamine oxidase) inhibitors and the tricyclic 
compounds (Goodman, Gilman, 1996).
The phenothiazinic derivatives were analyzed by 
Petit et al (1999), who developed a highly sensitive me-
thod (LOD = 10-8 mol.L-1) based on the use of Horseradish 
peroxidase and carbon electrodes coupled to FIA systems.
Many transducers have been proposed for neurolep-
tic detection which, despite presenting low redox activity, 
can be quantified by amperometric or potentiometric 
techniques. Hence, haloperidol presents an irreversible 
anodic peak (Epa ~0.86V) determined with glassy carbon 
electrodes modified with carbon nanotubes (Huang et al., 
2008). The ion-selective electrodes for chlorpromazine 
were prepared with chlorpromazine-tetraphenylborate 
complexes incorporated into matrices of PVC. This device 
was used in FIA systems, presenting a nerstian response 
from 1.0 x 10-5 to 1.0 x 10-2 mol.L-1(Sales, Tomas, Lavan-
deira, 2006). In other similar proposals, chlorpromazine 
was indirectly detected by ion selective electrodes of Pb2+. 
In this case, the drug was oxidized in an oxidative column 
fitted to an FIA system, where Pb2+ ions are delivered 
during the oxidative process. The delivery of Pb2+ was 
proportional to the chlorpromazine concentration, allo-
wing the indirect potentiometric detection of this analyte 
(Kojio, 1997). In both cases, the oxidase enzymes can be 
useful in oxidative systems.
Another HRP biosensor, constructed using enzyme 
immobilization in porous microparticles of silica magne-
tically linked to a glassy carbon electrode, was evaluated 
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for the amperometric analysis of clozapine. The analyti-
cal signal is generated during clozapine oxidation in the 
presence of hydrogen peroxide. Some interfering agents 
containing thiolic groups were also indirectly determined 
by means of signal inhibition (Blankert et al., 2004). The 
same technique of immobilization was used for HRP in 
carbon paste electrodes, which resulted in a device with 
higher enzymatic stability, equal sensitivity (LOD = 0.3 
µmol/L), but higher response time (Yu et al., 2006). In 
this case, the diffusion process of products is a limiting 
factor to obtaining lower response time (Yu, Blankert, 
Kauffmann, 2007).
The most commonly used biosensor for MAO inhi-
bitor analysis is based on monoamine oxidases (MAO) 
connected to amperometric transducers. The analysis of 
desipramine, pirlindole and fluoxitine was carried out 
using MAO biosensors, where the enzyme was immobi-
lized in screen printed platinum electrodes. The device 
presented high sensitivity, and the detection limits were 
8.0 x 10-9, 8.0 x 10-7 and 8.0 x 10-10 molL-1 for esipramine, 
pirlindole and fluoxetine, respectively (Medyantseva et al., 
2008). Hydrogen peroxide was detected in FIA systems 
containing immobilized MAO at 0.7 V. The amperometric 
sensor was a platinum electrode modified with polypyrrole 
films, which improves the selectivity of the analytical sig-
nal. In this case, the hydrogen peroxide production resulted 
from the activity of MAO on fluoxetine (Vela et al., 2003). 
Indeed, many HRP-based biosensors are grounded in the 
indirect detection of the analyte of interest.
The use of ion-selective electrodes was also applied 
in the potentiometric determination of the antidepressant 
nefazodone, a serotonin reuptake inhibitor (Erdem et al., 
2000). 
Cytotoxics agents
Many important physiological process and bioche-
mical cycles are based on redox chemical reactions, which 
involve multiple enzymatic steps. Hence, the electroche-
mical methods are valuable tools for the quantification 
and qualitative analysis, and for the obtention of relevant 
information on mechanism of action, and for the develo-
pment of new chemotherapeutic agents (La-Scalea et al, 
2001; La-Scalea et al, 2002; Goulart, 2006). 
However, the inherent complexity of biological sys-
tems can allow innumerous interactions between chemical 
species and the respective molecular target of action, so 
the rational use of biosensors and electrochemical techni-
ques can be very useful in understanding these processes. 
Among the main correlations of electrochemical data and 
biological properties are the following associations: a) 
electrochemical signal suppression or enhancement for the 
generation of toxic molecules or for specific biochemical 
reactions; b) current peaks for the number of electrons in-
volved in the endobiotic redox process; c) potentials shift 
in the drug binding on a molecular target of action (Brett, 
Serrano, 1995; Brett et al., 1999ª; Gil, Kubota, 2000; Gil 
et al., 2000; De-Abreu, Ferraz, Goulart, 2002). 
Among the main molecular targets of cytotoxic 
agents are the nucleic acids and functional enzymes of 
the parasite.
Beta-lactam antibiotics
The beta lactamases are hydrolytic enzymes produ-
ced by many bacteria, conferring to these microorganisms 
resistance to bet-lactam antibiotics such as penicillins, 
cephalosporins, cephamycins and carbapenems. The 
most-investigated biosensor is the device developed for 
penicilline analysis (Keusgen, 2002). The first biosensors 
for penicilline were based on penicilinase enzyme, a spe-
cific type of beta-lactamase. Beta-lactam ring hydrolysis 
generates penicilloic acid, which is detected by a poten-
tiometric sensor (Fernandes, 1999). Hence, the use of 
penicilinase connected to pH electrodes, is a very simple 
and classic alternative to β-lactamic compounds (Park 
et al, 2004; Papariello et al, 1973). Other procedures for 
β-lactamic analysis involve the use of optical biosensors 
(Cacciatore et al., 2004) and biosensors based on surface 
plasma resonance (SPR) (Gustavsson, Sternesjö, 2004). 
The ion-selective sensors for ampicillin and analogs are 
generally based on ionic exchange membranes. Shvedene 
and Borovskaya (2003) have described the use of mem-
branes produced by three different ionophores systems 
containing azo compounds and metallophthalocyanines, 
while Kulapina et al (2006) proposed the use of membra-
nes of tetradecylammonium (TDA).
In an innovative proposal, Caras and Janata (1980) 
described the construction of a field-effect transistor (FET) 
sensitive to pH, modified with pelicilinase. This technolo-
gy was developed in later research by Liu et al (1998), who 
proposed the concept of the ion-sensitive field-effect tran-
sistor (ISFET). The proposed ISFET responded linearly (r 
= 0.9944) from 0.5 to 8 mmolL-1. The great importance of 
ISFET can be attributed to its capacity to be miniaturized 
and employed in portables devices (Stradiotto et al., 2003; 
Fernandes et al., 2001).
An amperometric biosensor developed by the im-
mobilization of tyrosinase in rotary disc electrodes was 
evaluated for the indirect detection of penicillin. This 
system was based on the inhibition of current cathodic 
peaks. The enzymes oxidize cathecol to quinone, which 
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is electrochemically reduced at -150 mV. Penicillin was 
added to the same electrolytic cell which reacts with the 
o-quinone producing theoquinone, consequently decre-
asing the analytical signal. The decrease in current is 
proportional to the penicillin concentration, and results 
in a wide linear curve from 0.02 to 80 mM (r = 0.9990). 
The reproducibility of this indirect system was good (CV 
< 4.0%), and the stability was higher than one month 
(Torriero et al., 2006).
Antineoplastics
Neoplasias are diseases in which the growth of the 
cells, unable to work normally, exceeds that of healthy tis-
sues, suppressing the organic reserves surrounding normal 
tissues. The main target of antineoplastic agents is nucleic 
acids. The interaction between DNA or RNA and antine-
oplastic drug can be electrochemically monitored (Brett, 
Serrano, 1995; Brett, Piedade, Serrano, 2000). In such 
studies, the suppression of anodic peaks corresponding to 
the oxidation of purines and pyrimidines of nucleic acids 
are commonly observed before and after drug interaction 
(Gil et al., 2000). The magnitude of the alterations in the 
analytical signal (e.g. anodic peak suppression of adenine) 
can be associated to the drug concentration. Hence, nucleic 
acid modified electrodes have many applications in phar-
maceutical analysis including quality control, physiology 
and medicinal chemistry (Rauf et al., 2005; Erdem, Ozsoz, 
2002; Hason et al., 2002; Asphahani, Zhang, 2007). Fur-
thermore, such biopolymers often improve the many pro-
perties of the electrode, including the electron transfer rate 
and conductivity, both decreasing the current capacity and 
peak potentials (Brett, Serrano, 1995; Gil, Kubota, 2000).
Imidazolic compounds
The drugs presenting imidazolic rings are often 
cytotoxic, being employed in the treatment of mycoses, 
and other parasitic or bacterial infections (Goodman, 
Gilman, 1996). The mechanism of action involves a redox 
process that results in the production of free radicals. The 
nitroimidazoles, for example, are activated by reduction 
in hypoxic cells followed by a redox cycle that produces 
toxic compounds (Brett et al., 1997a, Brett et al., 1999b). 
DNA sensors have been successfully used to study 
this class of compound (Brett et al., 1997b). The electro-
chemical behavior of imidazolic compounds have been 
studied by DNA modified electrodes, not only for analyti-
cal purposes, but also in order to elucidate the mechanism, 
as well as the level of toxicity (Brett et al, 1996; Brett et 
al., 1997ª ; La-Scalea, 2002; Zhang et al., 2005).
However, many studies have described DNA mo-
dified sensors as conventional biosensors, but given the 
lack of selectivity of this recognizing agent the use of this 
term is controversial. 
Antraciclins and sulphonamides
Associations of DNA and enzymes have been propo-
sed for chemotherapeutic agents. This association results 
in signal amplification, either for conductive improvement 
of the transducer properties, or for pre-concentration of 
analyte on the electrode surface. The determination of an-
tracyclins and sulphonamides with glassy carbon ds-DNA 
and HRP modified electrodes was evaluated for these dru-
gs in the oxidation of methylene blue (electron mediator). 
The detection limits observed for the DNA-HRP-biosensor 
were 0.002 nmolL-1 for sulphamethoxazole, 0.1 nmolL-1 
for sulphadiazine, 0.01 nM for sulfamethazine, 0.1 nmolL-1 
for sulphaguanidine, 0.05 mmolL-1 for rubomycine, and 
of 0.08 mmolL-1 for doxorubicin (Evtugyn et al. , 2005). 
Tetracyclines and quinolones
In the case of antiparasitic drugs, the use of micro-
bial cells as recognizing agents is a promising strategy. 
In such devices, the influence of the drug on microbial 
metabolism and proliferation can be used as the principle 
of the analytical signal.
Traces of quinolones and tetracyclines were detec-
ted in milk samples by using a biosensor. The principle 
of detection was based on the potentiometric determina-
tion of carbon dioxide produced by microbial activity of 
Escherichia coli (ATCC 11303) microbial cultures, and 
detection limits above 25 mgL-1 were found. (Pellegrini, 
Carpico, Coni, 2004).
The indirect determination of tetracyclines based 
on the potentiometric detection of ammonium (Simpson, 
Kobos, 1984) or using selective modified PVC membranes 
for tetracycline have also been described (El-Ansary et 
al, 1999). The selectivity of these devices for drugs was 
evaluated in the presence of many ions, carbohydrates and 
aminoacids present in biological fluids and pharmaceutical 
preparations (El-Ansary et al, 1999).
Furthermore, the modification of polymeric mem-
branes with tetracycline has also been evaluated for 
calcium analysis, in the presence of mono and divalent 
cations (Baek, Rhee, Paeng, 2006).
A quantitative assay for ciprofloxacin, a quinoli-
nocarboxylic acid derivative, was proposed based on 
HRP-biosensors. The principle of detection was based 
on electrochemical reduction of quinones enzimatically 
Electrochemical biosensors in pharmaceutical analysis 383
formed on the electrode surface, which was blocked by 
piperazine groups of ciprofloxacin (Michael addition 
mechanism). Hence, in this indirect method, the current 
suppression was proportional to the ciprofloxacin amount. 
A linear curve was obtained for the concentration range 
0.02 to 65 mmol.L-1 (r = 0.999) with a detection limit of 
0.4 nmol.L-1, where the optimal experimental condition 
was observed in neutral pH (Torriero, 2006b). 
CONCLUSION
The real-time detection of substances is a tendency 
in analytical chemistry that can be achieved by the use of 
sensors. The development of biosensors is a promising 
tool that meets the requirements of low cost, simplicity of 
analysis, selectivity and good sensitivity.
This review briefly described some of the main ap-
plications of these devices for pharmaceutical analysis. In 
spite of the difficulties concerning the reproducibility of 
the electrochemical methods and stability of enzymes and 
other biological recognizing agents, the biosensor remains 
a focus of research. Hence, many studies on the develo-
pment of new material transducers, as well as techniques 
of immobilization of the recognizing agents can be found 
on literature. However, the consolidation of these devices 
for use in pharmaceutical analysis, and the introduction of 
official methods, requires further research.
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